Clinical trials
Recruiting Phase 3 Major Depressive Disorder trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
31 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 12 |
| 2026 | 11 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 31 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neurocrine Biosciences | 5 |
| Janssen Research & Development, LLC | 3 |
| Dr. Inge Winter | 2 |
| Eli Lilly and Company | 2 |
| Ain Shams University | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Axsome Therapeutics, Inc. | 1 |
| CSPC Ouyi Pharmaceutical Co., Ltd. | 1 |
| Cybin IRL Limited | 1 |
| Definium Therapeutics US, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Major Depressive Disorder | 31 |
| Depressive Disorder | 4 |
| Depressive Disorder, Treatment-Resistant | 4 |
| Stress Disorders, Post-Traumatic | 3 |
| Mood Disorders | 2 |
| Wounds and Injuries | 2 |
| Anxiety Disorders | 1 |
| Bipolar Disorder | 1 |
| Combat Disorders | 1 |
| Disorders of Excessive Somnolence | 1 |
Trials
Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.